Tag: Parkinson’s
Diagnostic Potential for Blood-Based NfL in Parkinson’s Disease
Blood neurofilament light chain levels may prove useful in both primary care and specialized clinics
Cognitive Stress Reduces Levodopa Effect in Parkinson’s
Levodopa effect significantly smaller during cognitive co-activation than during rest
Opicapone As Levodopa Adjunct Cuts Motor Fluctuations in PD
In Parkinson's disease, 50-mg/day opicapone linked to significant reduction in mean daily off-time
Gene Mutation Linked to Early-Onset Parkinson’s Disease
Mutated GCH1 gene tied to 23 percent increased risk of Parkinson's; symptoms five years earlier
Inhaled Levodopa May Rapidly Relieve Parkinson’s Symptoms
Levodopa pill can wear off, but a powdered version can help patients during off periods
Dementia, Mortality Risk Up for GBA Carriers With Parkinson’s
Mortality risk remained greater in carriers after introduction of dementia as time-dependent covariate
Statin Use Tied to Reduced Risk of Parkinson’s in Diabetes
Protective effects for all statins, except lovastatin; evidence of dose-dependent trend
Active Music Therapy Beneficial in Parkinson’s Disease
Beneficial effect in tests examining frontal lobe function and improvement in memory
Nilotinib Shows Early Promise for Parkinson’s Disease
Medication generally found safe, and study findings hint at a benefit
Traumatic Brain Injury Tied to Risk of Parkinson’s Disease
No association between TBI with loss of consciousness and increased dementia risk
